Biochemistry, Genetics and Molecular Biology
AKT1
6%
AMP-activated Protein Kinase
6%
Anticancer
9%
Autophagy
9%
Autotaxin
6%
BRCA1
11%
Cancer Cell
100%
Cancer Stem Cell
9%
Carcinogenesis
29%
Catenin
8%
Cell Cycle
12%
Cell Cycle Progression
6%
Cell Death
12%
Cell Growth
11%
Cell Invasion
8%
Cell Migration
12%
Cell Proliferation
24%
Cell Survival
9%
Cisplatin
7%
Clinical Trial
10%
DNA Damage
10%
DNA Damage Response
14%
DNA Methylation
14%
DNA Repair
14%
DNA Sequence
7%
Downregulation
10%
Drug Resistance
12%
Epidermal Growth Factor Receptor
25%
Epigenetics
14%
Estrogen Receptor
17%
extracellular signal regulated kinase
14%
Fibroblast
10%
Gene Dosage
8%
Gene Expression
36%
Gene Expression Data
6%
Gene Expression Profiling
19%
Gene Mutation
12%
Gene Signature
11%
Genetics
21%
Genome Instability
7%
Genomics
74%
Genotyping
7%
Germ Cell
7%
Growth Factor
8%
Homologous Recombination
8%
Immune Checkpoints
10%
Immunity
15%
Integrin
7%
Interleukin 2
8%
Isoform
11%
Kinase
29%
KRAS
7%
Long Non-Coding RNA
10%
Lysophosphatidic Acid
17%
Mammalian Target of Rapamycin
12%
Mediator
7%
Mesenchymal-Epithelial Transition
9%
Messenger RNA
23%
Metabolic Pathway
7%
Methylation
15%
MicroRNA
27%
Mouse Model
9%
N-Terminus
9%
Next Generation Sequencing
9%
Non-Coding RNA
7%
Oncogene
21%
Overall Survival
17%
P53
18%
Pan-cancer
8%
Phosphatase
8%
Phosphoinositide 3-Kinase
30%
Phosphotransferase
29%
Poly ADP Ribose Polymerase
12%
Programmed Cell Death
37%
Promoter Region
20%
Protein Expression
19%
Protein Kinase
7%
Protein Kinase B
20%
Protein Microarray
30%
Proteomics
30%
Receptor Tyrosine Kinase
11%
RNA
14%
RNA Sequence
8%
Single-Nucleotide Polymorphism
6%
Small Interfering RNA
11%
Somatic Mutation
13%
STAT3
8%
Stem Cell
12%
Synapsin I
8%
T Cell
12%
Transcription
11%
Transcription Factor
12%
Transcriptome
9%
Transcriptomics
7%
Tumor Progression
28%
Tumor Suppressor Gene
8%
Tumor Suppressor Protein
22%
Tyrosine Phosphorylation
7%
Upregulation
12%
Wild Type
12%
Medicine and Dentistry
Abdominal Cancer
6%
Antineoplastic Activity
5%
Autophagy
8%
Biological Marker
20%
Breast Cancer
53%
Cancer
22%
Cancer Cell
49%
Cancer Growth
10%
Cancer Therapy
12%
Cancer Types
6%
Carcinogenesis
16%
Cell Growth
6%
Cell Invasion
5%
Cell Line
14%
Cell Migration
6%
Cell Proliferation
10%
Cell Signaling Pathway
13%
Clinical Trial
6%
Combination Therapy
5%
Diseases
19%
DNA Repair
5%
Drug Resistance
8%
Epidermal Growth Factor Receptor
10%
Epithelial Cell
6%
Estrogen Receptor
7%
extracellular signal regulated kinase
9%
Gene Expression
14%
Gene Expression Profiling
8%
Gene Mutation
5%
Glioblastoma
8%
Growth Factor
6%
Head and Neck Squamous Cell Carcinoma
5%
Hepatocellular Carcinoma
11%
Immunity
5%
In Vitro
16%
Krukenberg Tumor
21%
Lung Cancer
8%
Lysophosphatidic Acid
9%
Malignant Neoplasm
51%
Mammalian Target of Rapamycin
5%
Melanoma
11%
Messenger RNA
9%
Metastatic Carcinoma
22%
microRNA
8%
Neoplasm
86%
Next Generation Sequencing
8%
Non Small Cell Lung Cancer
9%
Oncogene
6%
Ovarian Cancer
74%
Ovarian Cancer Cell Line
5%
Ovarian Tumor
6%
Overall Survival
10%
Personalized Medicine
5%
Phosphoinositide 3-Kinase
20%
Phosphotransferase
9%
Primary Tumor
7%
Programmed Cell Death
19%
Promoter Region
8%
Protein Expression
6%
Protein Kinase B
12%
Protein Microarray
10%
Protein P53
8%
Protein Tyrosine Kinase
5%
Proteomics
12%
Reactive Oxygen Species
5%
Receptor
9%
Recurrent Disease
10%
Small Interfering RNA
5%
Somatic Mutation
5%
Stem Cell
5%
T Cell
6%
Targeted Therapy
14%
The Cancer Genome Atlas
10%
Triple Negative Breast Cancer
8%
Tumor Cell
14%
Tumor Microenvironment
8%
Tumor Progression
18%
Upregulation
7%
Uterine Cancer
14%
Xenograft
9%
Keyphrases
AKT Pathway
5%
AKT1
5%
Apoptosis
16%
Autophagy
8%
Breast Cancer
35%
Breast Cancer Cells
12%
C-Jun N-terminal Kinase
6%
Ca2+
5%
Cancer Cells
13%
Cancer Genome Atlas
11%
Cancer Therapy
5%
Cancer Types
9%
Catenin
5%
Cell Growth
5%
Cell Proliferation
12%
Clinical Outcomes
5%
Clinical Significance
5%
Colorectal Cancer
5%
Confidence Interval
6%
DNA Damage Response
5%
Epidermal Growth Factor Receptor
7%
Epithelial Ovarian Cancer
6%
Estrogen Receptor
5%
Gene Expression
9%
Gene Signature
10%
Genetic Modification
6%
Glioblastoma
6%
Gonadotropin-releasing Hormone
5%
Growth Factors
10%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
6%
Hepatocellular Carcinoma
13%
High-grade Serous Ovarian Cancer (HGSOC)
7%
Human Cancer
8%
Human Epidermal Growth Factor Receptor 2 (HER2)
5%
In Cancer
24%
Induced Apoptosis
11%
Integrin
5%
Interleukin-2
15%
Jab1
7%
Knockdown
5%
Lung Cancer
5%
Lysophosphatidic Acid
10%
Mammalian Target of Rapamycin (mTOR)
8%
MEK Inhibitor (MEKi)
5%
Melanoma
6%
Metastasis
13%
MicroRNA
10%
Molecular Characterization
5%
Next-generation Sequencing
5%
Non-coding RNA (ncRNA)
5%
Non-small Cell Lung Cancer (NSCLC)
8%
Oncogene
10%
Ovarian Cancer
42%
Ovarian Cancer Cells
15%
Overall Survival
11%
Overexpression
13%
P27Kip1
5%
Paclitaxel
5%
PARP Inhibitor (PARPi)
8%
Phosphatidylinositol 3-kinase Pathway
5%
Phosphoinositide 3-kinase (PI3K)
24%
Phosphorylation
14%
PIK3CA
7%
PIK3CA mutation
5%
Poor Prognosis
11%
Primary Tumor
5%
Protein Expression
5%
Protein Kinase
9%
Putative Drug Targets
5%
Rapamycin
5%
Reverse Phase Protein Array
12%
Signaling Pathway
6%
Small Interfering RNA (siRNA)
8%
Soluble interleukin-2 Receptor (sIL-2R)
5%
T Cells
12%
Targeted Therapy
7%
Therapeutic Target
5%
Triple-negative Breast Cancer
5%
Tumor
44%
Tumor Cells
13%
Tumor Growth
8%
Tumor Microenvironment
6%
Tumor Progression
7%
Tumor Suppressor
8%
Tumor Suppressor Gene
5%
Tumorigenesis
7%
Tyrosine Kinase
7%
Tyrosine Phosphorylation
5%
Yes-associated Protein 1 (YAP1)
5%